CD19 and Alzheimer disease: The results showed that the percentages of NK1R+ cells in CD4+, CD8+, CD14+ and CD123+HLA-DR−, but not CD16+ and CD19+ cells, were elevated in the blood of AD patients in comparison with HC blood (Fig. 4a, b).